Diabetes 62:A257A257 Henderson SJ, Konkar A, Hornigold DC et al (2016) Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
Results from initial clinical trials suggest that GLP-1 medications promote smoking abstinence, reduce nicotine craving and withdrawal, and prevent weight gain that frequently occurs with smoking cessation
This treatment is often used for overall skin brightening and for reducing pigmentation
Kennedy is a big fan of peptides and has taken them himself, he told podcaster Joe Rogan in February
February 20, 2025: Ozempics Label Updated to Include Risks of Severe Injuries or Death Related to Pancreatic and Kidney Injuries The U.S
Given higher rates of cardiovascular and renal complications in lupus patients relative to the general population, lupus patients certainly stand to particularly benefit from GLP1-RA if they are proven safe in this patient population